facebook twitter instagram linkedin google youtube vimeo tumblr yelp rss email podcast phone blog search brokercheck brokercheck Play Pause
Understand the Business! Thumbnail

Understand the Business!

Simon cautions on judging an investment by the knee-jerk, post-earnings market reaction. He also discusses the potential pitfalls of trying to predict legislative outcomes, underappreciating "slow" risk, and the limitations of the widely-adopted "60/40" portfolio allocation. He highlights quarterly results from Johnson and Johnson (JNJ), AbbVie (ABBV), Merck (MRK), Amazon (AMZN), Northrop Grumman (NOC), and L3Harris Technologies (LHX).

Let Us Help Guide You